The authors respond

American Journal Geriatric Pharmacotherapy

Volumn 9, Issue 1, 2011, Pages 94-

  Wood, Lindy ^a   Neumiller, Joshua ^a   Setter, Stephen ^a   Dobbins, Erin ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETHANECHOL; LEVODOPA; MUSCARINIC RECEPTOR BLOCKING AGENT;

BLADDER DISEASE; BLADDER FUNCTION; BLADDER TRAINING; DRUG EFFICACY; HUMAN; LETTER; LIFESTYLE MODIFICATION; LONG TERM CARE; LOWER URINARY TRACT SYMPTOM; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; SHY DRAGER SYNDROME; SIDE EFFECT; URINARY DYSFUNCTION;

EID: 79953728757     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.01.001     Document Type: Letter

References (5)

1. Wood LD, Neumiller JJ, Setter SM, Dobbins EK. Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease. Am J Geriatr Pharmacother. 2010;8:294-315.
2. Araki I, Kuno S. Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score. J Neurol Neurosurg Psychiatry. 2000;68:429-433. (Pubitemid 30248741)
3. Campos-Sousa RN, Quagliato E, da Silva BB, et al. Urinary symptoms in Parkinson's disease: Prevalence and associated factors. Arq Neuropsiquiatr. 2003;61:359-363. (Pubitemid 36850893)
4. Brusa L, Petta F, Pisani A, et al. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease. Neurology. 2007;68:1455-1459. (Pubitemid 46685914)
5. Krishnamoorthy S, Kekre NS. Detrusor underactivity: To tone or not to tone the bladder? Indian J Urol. 2009;25:407-408.